Medical News

RSS

DATATRAK CRO Connect Program: Kreara Solutions joins global list

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that Kreara Solutions Pvt Ltd. has become the latest Contract Research Organization (CRO) to join the global list of DATATRAK CRO Connect partners.

8 Mar 2010

VIVUS granted three additional patents for Qnexa

VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.

8 Mar 2010

ThermalTherapeutic Systems receives FDA clearance for VERATHERM Portable Hyperthermic Perfusion System

ThermalTherapeutic Systems, Inc. today announced that the FDA has cleared the company to market its VERATHERM™ Portable Hyperthermic Perfusion System effective immediately.

8 Mar 2010

GeneGo's industry-FDA MetaTox partnership program: Tools and contents released

GeneGo announces the release of the first set of tools and content to come out of its industry-FDA MetaTox™ partnership program. The MetaTox partnership is developing a unique comprehensive systems toxicology suite designed for compound safety assessment in chemical and pharmaceutical R&D.

8 Mar 2010

New nutrition product to address effects of Glycation

After an extensive on going research program, Mineral BioSciences LLC a division of Global Organics Group is proud to announce the introduction of TOTALA® Nutrients, an ingredient that promises to have a profound effect on the nutrition industry.

8 Mar 2010

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.

8 Mar 2010

NICE rejects azacitidine for treatment of MDS in patients ineligible for stem cell transplants

A drug for treating a group of conditions that affect the bone marrow is unlikely to be made available on the NHS in England and Wales after the body which provides independent advice on treatments said that it is unlikely to be cost-effective.

8 Mar 2010

Centric Health's 2009 revenues up 132%

Centric Health Corporation, a diversified healthcare company, today announced its financial results for the fourth quarter and year ended December 31, 2009.

8 Mar 2010

Global Genes Project: World Rare Disease Day 2010, a tremendous success

The Global Genes Project, a worldwide rare disease awareness initiative, today announced the success from its World Rare Disease Day 2010 efforts and laid out plans for future rare disease awareness campaigns.

8 Mar 2010

Key Life Benefits, Boomer Authority partner to offer affordable health and lifestyle benefits

Boomer Authority™ and Key Life Benefits, a national resource for supplemental benefits, have partnered to offer businesses, individuals, social networking communities, and organizations health and lifestyle products and services at substantial cost saving prices.

8 Mar 2010

National Week of Prayer for the Healing of AIDS in the U.S. and the World

The National Week of Prayer for the Healing of AIDS begins Sunday, March 7th – Saturday, March 13th, 2010, with Churches, Synagogues, Temples and Homes calling Americans to teach, advocate and pray for the healing of AIDS in the United States and the World.

8 Mar 2010

Osteotech's MagniFuse Bone Graft generates $1M in revenue

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that its MagniFuse™ Bone Graft has generated its first $1 million in revenue during the four month period beginning with the limited launch of the product in late October 2009. Osteotech began the first phase of its strategic limited launch of MagniFuse with the release of three procedure specific forms for posterior cervical and posterolateral spine fusion and spinal deformity procedures.

8 Mar 2010

Lexicon Pharmaceuticals proposes $95 million underwritten public offering of common stock

Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.

8 Mar 2010

mtm laboratories launches CINtec PLUS screening system for cervical cancer

mtm laboratories, a privately held diagnostics company today announced the launch of CINtec® PLUS, the company’s next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer. CINtec® PLUS will be launched with claims direct in Germany, Italy, Spain, France and the UK, and will also be available in other parts of the world via mtm’s nominated distributors.

8 Mar 2010

First Edition: March 8, 2010

Today's headlines highlight how the health reform battle lines continue to take shape as President Obama takes his plan on the road, looking for public support.

8 Mar 2010

Quintiles opens expanded research facility in London

Quintiles today announced the opening of its expanded research facility in London, UK, increasing its Phase I capacity and extending its ability to drive progress in translational medicine.

8 Mar 2010

Evaluating asymptomatic diabetics for CHD: Speckle Tracking by Echo ultrasound substudy sponsored

Cardiovascular death is the most common cause of mortality among Type 2 diabetics and claims the lives of millions each year, with many diabetics experiencing their first “symptom” as a heart attack or sudden death. Understanding that diabetics are at high risk for Coronary Heart Disease (CHD) and that many with the disease are asymptomatic, Toshiba America Medical Systems, Inc., has sponsored Speckle Tracking by Echo, a faCTor64 substudy using Toshiba’s Wall Motion Tracking ultrasound technology.

8 Mar 2010

DaVita's presentations at ADC: New developments in the field of CKD, Vascular Access and Home Modalities

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will present 20 presentations at the 30th Annual Dialysis Conference scheduled for March 6 – 9 in Seattle.

8 Mar 2010

DiagnoCure: Global studies confirm clinical utility of PROGENSA PCA3 test

DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.

8 Mar 2010

KCI receives reimbursement approval for use of V.A.C. ATS Therapy System in Japan

Kinetic Concepts, Inc. today announced it has received reimbursement approval from Japan’s Health Insurance Bureau for use of the innovative V.A.C. ATS® Therapy System in the country. The approval signifies an important advancement in the company’s plans for market launch in April and follows Japan’s Ministry of Health, Labor and Welfare’s decision in November 2009 to grant final regulatory approval for the product.

8 Mar 2010

Medical News

DATATRAK CRO Connect Program: Kreara Solutions joins global list

VIVUS granted three additional patents for Qnexa

ThermalTherapeutic Systems receives FDA clearance for VERATHERM Portable Hyperthermic Perfusion System

GeneGo's industry-FDA MetaTox partnership program: Tools and contents released

New nutrition product to address effects of Glycation

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

NICE rejects azacitidine for treatment of MDS in patients ineligible for stem cell transplants

Centric Health's 2009 revenues up 132%

Global Genes Project: World Rare Disease Day 2010, a tremendous success

Key Life Benefits, Boomer Authority partner to offer affordable health and lifestyle benefits

National Week of Prayer for the Healing of AIDS in the U.S. and the World

Osteotech's MagniFuse Bone Graft generates $1M in revenue

Lexicon Pharmaceuticals proposes $95 million underwritten public offering of common stock

mtm laboratories launches CINtec PLUS screening system for cervical cancer

First Edition: March 8, 2010

Quintiles opens expanded research facility in London

Evaluating asymptomatic diabetics for CHD: Speckle Tracking by Echo ultrasound substudy sponsored

DaVita's presentations at ADC: New developments in the field of CKD, Vascular Access and Home Modalities

DiagnoCure: Global studies confirm clinical utility of PROGENSA PCA3 test

KCI receives reimbursement approval for use of V.A.C. ATS Therapy System in Japan

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News